Press Release
Posted by Repositive, March 2021
Connecting biopharmas with the right preclinical cancer models and CRO partners
Through our world-leading preclinical cancer models directory and CRO partner network, we can connect you with the right cancer model for your research.
We make model searching hassle-free so you can spend more time focusing on your research.
Connect with CROs around the world and access new models and technologies in one place.
Our independent experts collect all the data you need to make an informed decision.
When you want instant access to browse cancer models available globally, our online platform presents the world's largest cancer models inventory compiled of over 8000+ models available from our 24 CRO partners. Our platform gives your team a powerful tool to browse for suitable models to plan their experiments without delay. Give your whole team a tool to browse for suitable models in real time to plan their experiments.
We conduct a comprehensive search based on a well-defined scope of your needs and results are delivered within 2-4 weeks in a data-rich report of all identified matching models across CROs in our network. Let us do all the heavy lifting for you by activating our expert team.
Contact us for pricing.
Cancer Model Platform
Basic
+
Search by primary site, model type and cancer subtype
Online support
CANCER MODEL PLATFORM
Full Access
+
Everything in Basic, plus:
Secure account access
Molecular search (SNPs)
Additional model data on request
1 dedicated account manager
Drug treatment filters
Multiple gene mutation search
Multiple variant search
CANCER MODEL SCOUT
Custom
I was not aware of these models. You also provided me with details of the bioinformatics work, this is rarely clear.
It has been very useful to understand what models are out there, which is especially important when planning projects and budgets. Having access to smaller companies, which we never knew existed, is truly invaluable and Repositive’s support throughout has been very professional.
The quality of the report is good, the matching ranking and confidence level is the same as I would have done, I like the level of detail of on mutation type and variant.